Similar articles

• Vasoconstrictor therapy in bleeding esophageal varices.

  Walker S. Walker S. Hepatogastroenterology. 1990 Dec;37(6):538-43. Hepatogastroenterology. 1990. PMID: 1981203 Review. No abstract available.
• Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage.

  Seo YS, Park SY, Kim MY, Kim JH, Park JY, Yim HJ, Jang BK, Kim HS, Hahn T, Kim BI, Heo J, An H, Tak WY, Baik SK, Han KH, Hwang JS, Park SH, Cho M, Um SH. Seo YS, et al. Hepatology. 2014 Sep;60(3):954-63. doi: 10.1002/hep.27006. Epub 2014 Jul 25. Hepatology. 2014. PMID: 24415445 Clinical Trial.
• [Drug therapy of hemorrhage in esophageal and gastric varices: role of vasoactive drugs].

  Pulanić R. Pulanić R. Lijec Vjesn. 2000 Nov-Dec;122(11-12):276-83. Lijec Vjesn. 2000. PMID: 11291271 Croatian.
• Approach to the management of bleeding esophageal varices: role of somatostatin.

  Avgerinos A. Avgerinos A. Digestion. 1998;59 Suppl 1:1-22. doi: 10.1159/000051408. Digestion. 1998. PMID: 9603441 Review.
• [Drug therapy of acute esophageal varices bleeding (vasopressin, terlipressin, somatostatin)].

  Walker S. Walker S. Praxis (Bern 1994). 1995 Dec 19;84(51-52):1538-9. Praxis (Bern 1994). 1995. PMID: 8571017 German. No abstract available.